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in cell culture (Stroschein-Stevenson
et al., 2006), suggesting that size of the
engulfed particle may not be the rele-
vant parameter that distinguishes en-
gulfment of corpses from other forms
of phagocytosis. Thus, the determina-
tion of the processs regulated by the
PALL-SCF complex is a priority for fur-
ther investigations. Importantly, it will
be interesting to determine whether
SCF complexes and the proteasome
are required for the clearance of apo-
ptotic cells in amoebes, nematodes,
and mammals.
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Typically, dendritic cells (DCs) induce peripheral tolerance under steady state but immunity during
inflammation or infection. In this issue of Immunity, Jiang et al. (2007) identify disruption of E-cadherin
interactions as a unique maturation pathway by which DCs are capable of mediating tolerance.The induction of an efficient and pro-
tective immune response depends on
the interaction between naive antigen-
specific T cells and professional anti-
gen-presenting cells (APCs). Because
of their unique features, such asmigra-
tory capacity and expression of costi-
mulatory molecules, dendritic cells
(DCs) are considered the prototypic
professional APCs. DCs are present as
sentinels in peripheral tissues, where
they capture antigens that may be pre-
sented to CD4+ and CD8+ T cells. DCs
undergo a maturation process after
sensing pathogen-derived structures
through pattern recognition receptors
such as Toll-like receptors (TLRs), ex-
posure to proinflammatory cytokines,
or after ligation of the surface receptor
CD40. Uponmaturation, DCs stop tak-
ing up antigens, change their pattern
of homing receptors (e.g., upregulation
of CCR7; Roake et al., 1995), which
allows them to migrate into the T cell544 Immunity 27, October 2007 ª2007 Eareas of secondary lymphoid organs,
and upregulate costimulatory mole-
cules such as CD86. These changes
enable efficient priming of naive anti-
gen-specific T cells.
Under steady state, most DCs in
peripheral tissues have an immature
phenotype. They efficiently take up
antigens but lack high expression of
costimulatory molecules and CCR7
and thus can’t productively activate
naive T cells to develop into effectors.
Rather, it was thought that the interac-
tion of naive T cells with immature DCs
results in the induction of peripheral
T cell tolerance (Probst et al., 2005;
Steinman et al., 2003) in a T cell-intrin-
sic (e.g., anergy, deletion) or -extrinsic
(e.g., via T regulatory [Treg] cells or
cytokines) fashion (Probst et al., 2005;
Sakaguchi,2004;Steinmanetal., 2003).
The contact between naive T cells and
DCs is thought to take place in T cell
areas of secondary lymhoid organs,lsevier Inc.which requires the DCs in the peri-
pheral tissues tomove there. However,
althoughmature DCs with upregulated
expression of CCR7 could migrate
to the secondary lymphoid organs
(Roake et al., 1995), how immature
DCs reach these organs is less clear.
Langerhans cells (LCs), a subset of
DCs that reside in mucosal epithelia
and epidermis, form a 3-dimensional
network and adhere to surrounding
keratinocytes through the homophilic
adhesion molecule E-cadherin. It has
been shown that LCs migrate into the
cutaneous lymph nodes under steady-
state conditions, albeit much slower
than after mechanical trauma (Kis-
senpfennig et al., 2005). Along the
same line, E-cadherin was found to
be markedly downregulated on LCs
upon theirmaturation,whichmayallow
LCs to more efficiently leave the epi-
dermis and migrate into cutaneous
lymph nodes, where they (in)directly
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Previewspresent antigen to T cells. Moreover, li-
gation of E-cadherin on immature LCs
inhibits their maturation (Riedl et al.,
2000), which is probably an effective
way to prevent uncontrolled matura-
tion of APCs.
In this issue of Immunity, Jiang et al.
(2007) address the role of E-cadherin-
dependent adhesion in the process of
DC maturation (Figure 1). They find
that disruption of E-cadherin-medi-
ated interactions results in maturation
of DCs into cells that, surprisingly, do
not induce effector function in T cells,
but rather induce T cell tolerance and
presumably support the development
of Treg cells. That mechanical disrup-
tion of DC clusters in vitro resulted in
upregulation of costimulatory mole-
cules on DCs has been shown earlier,
but the underlying mechanism and the
functional status of the DCs were not
investigated previously (Gallucci et al.,
1999). First, Jiang et al. (2007) disrup-
ted the spontaneous clusters that are
formed in culture by developing DCs.
This cluster disruption (CD) leads to
upregulation of CD86, downregulation
of macropinocytosis, and redistribu-
tion of major histocompatibility com-
plex class II molecules, all indicative
of DC maturation. That loss of E-cad-
herin contacts is responsible for matu-
ration was shown by the fact that addi-
tion of an E-cadherin antibody to the
culturespreventsDCmaturation. Thus,
Jiang et al. (2007) postulated that alter-
ations in E-cadherin interactions in-
duce DC maturation, similar to what
was found for LCs (Riedl et al., 2000).
E-cadherin forms a complex with b-
catenin, which controls interactions
with the cytoskeleton and acts as tran-
scriptional cofactor upon transloca-
tion to the nucleus. The cytoplasmic
content of b-catenin is low in steady
state, partly because the bulk of b-cat-
enin is associated with the cytoplas-
mic domain of E-cadherin and also
partly because of glycogen synthase
3b (GSK3b)-mediated phosphorylation
and subsequent proteasomal degra-
dation. By using immunoprecipita-
tion and reporter assays, Jiang et al.
(2007) find that disruption of E-cad-
herin-mediated adhesion activates
b-catenin and the b-catenin-depen-
dent transcriptional activator TCF in
DCs, as has been shown before inother cell types (Nelson and Nusse,
2004). In line with these findings, the
artificial increase of cytosolic b-cate-
nin in DCs by the selective inhibition
of GSK3b resulted in DC maturation.
Next, the authors asked the impor-
tant question of whether DCs matured
by changes in E-cadherin interactions
functionally resembled DCs matured
by TLR ligation (e.g., the bacteria
Figure 1. Induction of Tolerance by
Cluster-Disrupted DCs
DCs are attached to surrounding cells (gray
cells) by E-cadherin. Disruption of these inter-
actions results in a particular activation path-
way of DC as described by Jiang et al. (2007).
As a result, DCs upregulate costimulatory mol-
ecules and MHC and also CCR7, which allows
migration into the T cell area of secondary lym-
phoid organs. The activation of DCs by loss of
E-cadherin interactions, however, does not in-
duce the production of cytokines. Upon arrival
to the secondary lymphoid organ, these DCs
tolerize naive T cells.Immunity 2E. coli or the bacterial product LPS).
They performed a genome-wide mi-
croarray analysis and found that dur-
ing the first few hours after stimulation
by CD or TLR, the gene expression
profiles in both groups were similar.
However, in the subsequent phase,
CD- and TLR-matured DCs seemed
to embark on a diverging path. The
most striking difference between the
two groups is the complete absence
of IL-1a, IL-6, TNF-a, and IL-12 p40
production by CD-matured DCs. Im-
portantly, both groups showed up-
regulated CCR7, which is crucial for
migration into secondary lymhoid or-
gans (Roake et al., 1995) and subse-
quent contact with naive T cells. When
maturation was induced by LPS and
CD simultaneously, a phenotype simi-
lar to that after LPS alone occurred,
suggesting that TLR signals dominate
over CD. However, if CD was per-
formed 12 hr before the TLR signal,
the production of some cytokines (IL-
1, IL-6, TNF-a) was inhibited, whereas
the production of IL-12 p40 was en-
hanced.
Although the interaction between
naive ovalbumin-specific CD4+ and
CD8+ T cells and ovalbumin-loaded
CD-matured DCs resulted in IL-2 pro-
duction in vitro, CD-matured DCs do
not appear to be immunogenic in vivo.
Hence, CD-matured DCs induced
adoptively transferred naive CD4+ and
CD8+ T cells to proliferate in an anti-
gen-specific fashion, but they did not
driveCD4+Tcells to produce IFN-g. In-
stead, theseCD4+ T cells secrete IL-10
and express elevated amounts of the
transcription factor Foxp3. This pheno-
type suggests that CD-matured DCs
support the development of Treg cells
rather than effector T cells. Jiang et al.
(2007) subsequently show that CD-
matured DCs could induce peripheral
tolerance and thereby prevent disease
in an experimental autoimmune en-
cephalomyelitis model.
Although Jiang et al. (2007) have
provided evidence for how DCs could
mediate tolerance in vivo under steady
state (in the absence of inflammatory
signals) and a possible mechanism of
how DCs could achieve a unique state
of maturation to accomplish this task,
several important questions remain.
First, does the equivalent of in vitro7, October 2007 ª2007 Elsevier Inc. 545
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Previewsgenerated cluster-disrupted DCs truly
exist in vivo? Second, is DC-specific
disruption of E-cadherin interaction a
physiological mechanism by which
immature DCs develop into DCs that
induce peripheral T cell tolerance to
tissue-specific self-antigens? Disrup-
tion of E-cadherin interactions may
allow DCs to leave peripheral tissues,
and the subsequent upregulation of
CCR7 may direct them to the T cell
areas of secondary lymphoid organs.
The events that induce disruption
under steady-state conditions in vivo,
however, are unclear, especially if one
considers that this event must take
place continuously and on a relatively
large scale to guarantee efficient in-
duction of peripheral tolerance to tis-
sue-specific self antigens, and given
the limited lifetime of a DC. Jiang et al.
(2007) suggest that traumata may be
responsible for disruption of E-cad-
herin interactions of DCs and their sub-
sequent maturation into tolerogenic
APCs. However, most traumata are
accompanied by the production of
inflammatory mediators, which would
result in mature DCs that prime ratherT Helper 17 Cells
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this issue of Immunity, van Beele
from memory T cells through act
In 1986, Mosmann and Coffman intro-
duced the Th1-Th2 paradigm by dem-
onstrating that helper T (Th) cells could
be separated into stable subsets that
produced distinct patterns of effector
cytokines (Mosmann et al., 1986).
Over the years since this discovery, it
has become clear that Th cells, under
the guidance of innate immune path-
ways, differentiate to tailor the adap-
546 Immunity 27, October 2007 ª2007 Ethan tolerize. Moreover, it is unclear
whether, in steady state, traumata oc-
cur continuously and ubiquitously. An
exception, as suggested by the au-
thors, may be skin and gut, which are
subjected to movements. An alterna-
tive possibility may be that disruption
of E-cadherin interactions is not ac-
tively induced by an extrinsic event
(e.g., trauma) but that it is intrinsically
programmed to occur at some point
during the DC’s life. Finally, should
the concept that resting immature DC
induce peripheral tolerance (Probst
et al., 2005; Steinman et al., 2003)
be modified, or do both mechanisms
of tolerance induction exist next to
each other? Investigation into whether
molecules suchas the inhibitory recep-
tor PD-1, transforming growth factor-
b, and indoleamine-2,3-dioxygenase
(Mellor and Munn, 2004; Probst et al.,
2005) also play a role in tolerance
mediated by CD-matured DCs may
clarify this issue, because involvement
of similar surface and intracellular mol-
ecules in both pathways at least sug-
gests that they are related, if not the
same.Get the NOD
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elper T cells play a role in pathoge
n et al. (2007) reveal a pathway tha
ivation of the intracellular receptor
tive immune response to the nature
of the microbial threat. In general,
Th1 cells are important for protection
against viruses and intracellular bac-
teria, whereas Th2 cells coordinate im-
munity to extracellular parasites atmu-
cosal surfaces. One of the enduring
features of the Th1-Th2 model is its
predictive power: The properties of
an effector Th cell reflect a specific mi-
lsevier Inc.REFERENCES
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crobial stimulus, interpreted by an an-
tigen-presenting cell and relayed to
the naive T cell in the form of MHC-
peptide complexes, inducible costi-
mulation, and instructive cytokines.
As we have learned more about the
innate immune pathways that detect
infection and characterized more of
the 75 cytokines in the mammalian
genome, the possibilities for other
